100 related articles for article (PubMed ID: 2327399)
1. Cigarette smoking, blast crisis, and survival in chronic myeloid leukemia.
Herr R; Ferguson J; Myers N; Rovira D; Robinson WA
Am J Hematol; 1990 May; 34(1):1-4. PubMed ID: 2327399
[TBL] [Abstract][Full Text] [Related]
2. Influence of cigarette smoking on the presentation and course of chronic myelogenous leukemia.
Archimbaud E; Maupas J; Lecluze-Palazzolo C; Fiere D; Viala JJ
Cancer; 1989 May; 63(10):2060-5. PubMed ID: 2702575
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of 30 cases of chronic myeloid leukemia with non-myeloid blast crisis].
Ge CW; Li DG; Hao YM
Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):731-3, 768. PubMed ID: 2636091
[TBL] [Abstract][Full Text] [Related]
4. [Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia].
Jonte F; Fernández-Fuertes F; Cecchini C; Luño E; Ordóñez A; Fernández C; Suárez P; Lausín A; Fernández J
Sangre (Barc); 1992 Oct; 37(5):351-4. PubMed ID: 1293774
[TBL] [Abstract][Full Text] [Related]
5. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
Cohen MH; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Jan; 11(1):12-9. PubMed ID: 15671523
[TBL] [Abstract][Full Text] [Related]
6. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
7. Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia in accelerated phase and blast phase: a retrospective analysis.
Thota NK; Gundeti S; Linga VG; Coca P; Tara RP;
Indian J Cancer; 2014; 51(1):5-9. PubMed ID: 24947087
[TBL] [Abstract][Full Text] [Related]
8. [Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients].
Creutzig U; Ritter J; Zimmermann M; Klingebiel T
Klin Padiatr; 1996; 208(4):236-41. PubMed ID: 8926689
[TBL] [Abstract][Full Text] [Related]
9. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival.
Urbano-Ispizua A; Cervantes F; Matutes E; Villamor N; Pujades A; Sierra J; Feliu E; Vives-Corrons JL; Montserrat E; Rozman C
Leukemia; 1993 Sep; 7(9):1349-54. PubMed ID: 8371586
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
Jain P; Kantarjian HM; Ghorab A; Sasaki K; Jabbour EJ; Nogueras Gonzalez G; Kanagal-Shamanna R; Issa GC; Garcia-Manero G; Kc D; Dellasala S; Pierce S; Konopleva M; Wierda WG; Verstovsek S; Daver NG; Kadia TM; Borthakur G; O'Brien S; Estrov Z; Ravandi F; Cortes JE
Cancer; 2017 Nov; 123(22):4391-4402. PubMed ID: 28743165
[TBL] [Abstract][Full Text] [Related]
12. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
Liu YL; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
[TBL] [Abstract][Full Text] [Related]
13. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis in chronic myeloid leukemia].
Robak T
Acta Haematol Pol; 1992; 23(1):11-20. PubMed ID: 1615747
[TBL] [Abstract][Full Text] [Related]
15. Nodal T cell blast crisis in chronic myeloid leukemia.
Lucero G; Birman V; Colimodio E; Bertinetti CM; Kotliar N; Murolo P; Irusta O; Klimovsky J; Koziner B
Leuk Lymphoma; 2000 Oct; 39(3-4):435-40. PubMed ID: 11342326
[TBL] [Abstract][Full Text] [Related]
16. Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib.
Koh Y; Kim I; Yoon SS; Kim BK; Kim DY; Lee JH; Lee KH; Park E; Kim HJ; Sohn SK; Joo YD; Kim SJ; Chung J; Shin HJ; Kim SH; Kim CS; Song HS; Kim MK; Hyun MS; Ahn JS; Jung CW; Park S;
Ann Hematol; 2010 Jul; 89(7):725-31. PubMed ID: 20179930
[TBL] [Abstract][Full Text] [Related]
17. Promyelocytic blast crisis of chronic myelogenous leukemia. A rare subtype associated with disseminated intravascular coagulation.
Rosenthal NS; Knapp D; Farhi DC
Am J Clin Pathol; 1995 Feb; 103(2):185-8. PubMed ID: 7856560
[TBL] [Abstract][Full Text] [Related]
18. T-cell blast crisis in chronic myelogenous leukemia. Immunophenotypic and molecular biologic findings.
Dorfman DM; Longtine JA; Fox EA; Weinberg DS; Pinkus GS
Am J Clin Pathol; 1997 Feb; 107(2):168-76. PubMed ID: 9024065
[TBL] [Abstract][Full Text] [Related]
19. Influence of cigarette smoking on the presentation and course of acute myeloid leukemia.
Chelghoum Y; Danaïla C; Belhabri A; Charrin C; Le QH; Michallet M; Fiere D; Thomas X
Ann Oncol; 2002 Oct; 13(10):1621-7. PubMed ID: 12377652
[TBL] [Abstract][Full Text] [Related]
20. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
